A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, multi-center clinical trial to evaluate the safety and efficacy of
TQ-B3139 capsules in patients with MET gene abnormal advanced non-small cell lung cancer.